Depomed Earns $10 Mln Milestone for FDA Approval of Mallinckrodt’s XARTEMIS XR – Stock FirmerBy Ryan WallaceMarch 12, 2014 Depomed, Inc. (DEPO) gains Wednesday, getting a milestone payment after the FDA approved Mallinckrodt plc’s New Drug Application (NDA) for…